Innate Pharma (IPHA) Retained Earnings (2017 - 2025)
Innate Pharma (IPHA) reported Retained Earnings of -$57.2 million for Q4 2025, up 84.1% on a YoY basis from -$31.1 million in Q4 2024, and down 4335.41% quarter-over-quarter from $1.4 million in Q2 2025.
Innate Pharma (IPHA) Retained Earnings (2017 - 2025) Analysis & Trends
Innate Pharma has reported Retained Earnings for 9 years, with the latest figure at -$57.2 million in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings rose 84.1% year-over-year to -$57.2 million; the trailing twelve-month figure through Dec 2025 stood at -$57.2 million (up 84.1% YoY), and the FY2025 full-year result was -$57.2 million, up 84.1% from the prior year.
- Retained Earnings for Q4 2025 stood at -$57.2 million, down from $1.4 million in the prior quarter.
- The five-year high for Retained Earnings was $1.4 million in Q2 2025, with the low at -$360.0 million in Q4 2024.
- Historically, Retained Earnings has averaged -$42.0 million across 5 years, with a median of $451434.5 in 2021.
- Annual changes were most pronounced in 2023 — Retained Earnings surged 282.33% — and 2024, when it sank 4319.99%.
- Innate Pharma's Retained Earnings stood at $521650.8 in 2021, then soared by 60.18% to $835582.6 in 2022, then slumped by 1074.75% to -$8.1 million in 2023, then slumped by 4319.99% to -$360.0 million in 2024, then jumped by 84.1% to -$57.2 million in 2025.
- The last three Retained Earnings figures came in at -$57.2 million (Q4 2025), $1.4 million (Q2 2025), and -$360.0 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -838.07 Mn |
| 10 | Innate Pharma | 194.19 Mn | 194.19 Mn | - | -57.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -57.24 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Dec 31, 2024 | -360.00 Mn |
| Jun 30, 2024 | 381,218.20 |
| Dec 31, 2023 | -8.14 Mn |
| Jun 30, 2023 | 1.16 Mn |
| Dec 31, 2022 | 835,582.59 |
| Jun 30, 2022 | 303,044.10 |
| Dec 31, 2021 | 521,650.75 |
| Jun 30, 2021 | 861,054.08 |
| Dec 31, 2020 | 423,262.90 |
| Jun 30, 2020 | -568.00 Mn |
| Dec 31, 2019 | -522,450.98 |
| Dec 31, 2018 | -157.47 Mn |
| Dec 31, 2017 | -106.09 Mn |